2016, Número 6
<< Anterior Siguiente >>
Ann Hepatol 2016; 15 (6)
Percutaneous shunt reduction for the management of TIPS-induced acute liver decompensation: A follow-up study
De Keyzer, Bart; Nevens F, Laenen A, Heye S, Laleman W, Verslype C, van der Merwe S, Maleux G
Idioma: Ingles.
Referencias bibliográficas: 13
Paginas: 911-917
Archivo PDF: 135.97 Kb.
RESUMEN
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Suhocki P, Lungren M, Kapoor B, Kim C. Transjugular intrahepatic portosystemic shunt complication: prevention and management. Semin Intervent Radiol 2015; 32: 123-32. 2 Laleman W, Verbeke L, Meersseman P, Wauters J, van Pelt J, Cassiman D, Wilmer A, et al. Acute-on-chronic liver failure: current concepts on definition,pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol 2011; 5: 523-37.
Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, et al; CANONIC Study Investigators of the EASLCLIF Consortium. Acute-on-Chronic Liver Failure is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis. Gastroenterology 2013; 144: 1426-37.
Verbeke L, Nevens F, Laleman W. Bench-to-bedside review: Acute-on-chronic liver failure – linking the gut, liver and systemic circulation. Critical Care 2011; 15: 233-44.
Haskal Z, Cope C, Soulen M, Shlansky-Goldberg R, Baum R, Redd D. Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology 1995; 195: 485-8.
Hauenstein K, Haag K, Ochs A, Langer M, Rössle M. The reducing stent: treatment for transjugular intrahepatic shunt-induced refractory hepatic encephalopathy and liver failure. Radiology 1995; 194: 175-9.
Sze D, Hwang G, Kao J, Frisoli J, Kee S, Razavi M, Ahmed A. Bidirectionally adjustable TIPS reduction by parallel stent and stent-graft deployment. J Vasc Interv Radiol 2008; 19: 1653-8.
Maleux G, Verslype C, Heye S, Wilms G, Marchal G, Nevens F. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: Preliminary experience with reduction stents and stent-grafts. AJR Am J Roentgenol 2007; 188: 659-64.
Cookson DT, Zaman Z, Gordon-Smith J, Ireland H, Hayes P. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: Outcomes of a retrospective case series. Cardiovasc Intervent Radiol 2011; 34: 92-9.
Maleux G, Heye S, Verslype C, Nevens F. Management of transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy with the parallel technique: Results of a clinical follow-up study. J Vasc Interv Radiol 2007; 18: 986-93.
Maleux G, Nevens F, Wilmer A, Heye S, Verslype C, Thijs M, Wilms G. Early and long-term clinical and radiological followup results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur Radiol 2004; 14: 1842-50.
Casadaban LC, Parvinian A, Couture PM, Minocha J, Knuttinen MG, Bui JT, Gaba RC. Characterization of liver function parameter alterations after transjugular intrahepatic portosystemic shunt creation and association with early mortality. AJR Am J Roentgenol 2014; 203: 1363-70.
Casadaban L, Gabra M, Parvinian A, Minocha J, Knuttinen M, Bui J, Gaba R. Impact of transjugular intrahepatic portosystemic shunt creation on intermediate-term model for endstage liver disease score progression. Transplant Proc 2014; 46: 1384-8.
Gaba R, Couture P, Bui J, Knuttinen M, Walzer N, Kallwitz E, Berkes J, et al. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2013; 24: 411-20, 420.e1-4; quiz 421.